Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CCM vs USPH vs RDNT vs AFCG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCM
Concord Medical Services Holdings Limited

Medical - Care Facilities

HealthcareNYSE • CN
Market Cap$748K
5Y Perf.-86.6%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-43.3%
RDNT
RadNet, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.45B
5Y Perf.+164.4%
AFCG
Advanced Flower Capital Inc.

REIT - Specialty

Real EstateNASDAQ • US
Market Cap$73M
5Y Perf.-78.5%

CCM vs USPH vs RDNT vs AFCG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCM logoCCM
USPH logoUSPH
RDNT logoRDNT
AFCG logoAFCG
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Diagnostics & ResearchREIT - Specialty
Market Cap$748K$897M$4.45B$73M
Revenue (TTM)$366M$695M$2.04B$6M
Net Income (TTM)$-163M$11M$47M$-20M
Gross Margin-11.4%22.0%11.2%-76.6%
Operating Margin-131.0%12.2%3.0%-124.7%
Forward P/E1.2x20.6x91.8x
Total Debt$3.93B$426M$1.86B$76M
Cash & Equiv.$216M$36M$767M$39M

CCM vs USPH vs RDNT vs AFCGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCM
USPH
RDNT
AFCG
StockMar 21May 26Return
Concord Medical Ser… (CCM)10013.4-86.6%
U.S. Physical Thera… (USPH)10056.7-43.3%
RadNet, Inc. (RDNT)100264.4+164.4%
Advanced Flower Cap… (AFCG)10021.5-78.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCM vs USPH vs RDNT vs AFCG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: RDNT leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Concord Medical Services Holdings Limited is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. USPH also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CCM
Concord Medical Services Holdings Limited
The Value Play

CCM is the #2 pick in this set and the best alternative if value and stability is your priority.

  • Lower P/E (1.2x vs 91.8x)
  • Beta 0.53 vs AFCG's 1.86
Best for: value and stability
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • Lower volatility, beta 0.93, Low D/E 55.3%, current ratio 1.01x
  • Beta 0.93, yield 3.1%, current ratio 1.01x
Best for: income & stability and growth exposure
RDNT
RadNet, Inc.
The Long-Run Compounder

RDNT carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 9.5% 10Y total return vs USPH's 22.6%
  • 2.3% margin vs AFCG's -333.9%
  • +4.6% vs AFCG's -35.5%
  • 1.3% ROA vs AFCG's -6.4%, ROIC 2.0% vs -4.1%
Best for: long-term compounding
AFCG
Advanced Flower Capital Inc.
The REIT Holding

AFCG lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: real estate exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs AFCG's -39.6%
ValueCCM logoCCMLower P/E (1.2x vs 91.8x)
Quality / MarginsRDNT logoRDNT2.3% margin vs AFCG's -333.9%
Stability / SafetyCCM logoCCMBeta 0.53 vs AFCG's 1.86
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs AFCG's 28.1%, (2 stocks pay no dividend)
Momentum (1Y)RDNT logoRDNT+4.6% vs AFCG's -35.5%
Efficiency (ROA)RDNT logoRDNT1.3% ROA vs AFCG's -6.4%, ROIC 2.0% vs -4.1%

CCM vs USPH vs RDNT vs AFCG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
RDNTRadNet, Inc.
FY 2025
Commercial Insurance1
58.8%$1.1B
Medicare1
24.8%$477M
Capitation Arrangements
6.5%$126M
Health Care, Other
3.4%$65M
Medicaid1
2.7%$52M
Workers' Compensation/Personal Injury1
2.3%$45M
Health Care, Management Service
1.4%$28M
AFCGAdvanced Flower Capital Inc.

Segment breakdown not available.

CCM vs USPH vs RDNT vs AFCG — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSPHLAGGINGAFCG

Income & Cash Flow (Last 12 Months)

USPH leads this category, winning 3 of 6 comparable metrics.

RDNT is the larger business by revenue, generating $2.0B annually — 342.1x AFCG's $6M. RDNT is the more profitable business, keeping 2.3% of every revenue dollar as net income compared to AFCG's -3.3%. On growth, AFCG holds the edge at +64.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
RevenueTrailing 12 months$366M$695M$2.0B$6M
EBITDAEarnings before interest/tax-$359M$107M$214M-$16M
Net IncomeAfter-tax profit-$163M$11M$47M-$20M
Free Cash FlowCash after capex$0$67M-$178M-$24M
Gross MarginGross profit ÷ Revenue-11.4%+22.0%+11.2%-76.6%
Operating MarginEBIT ÷ Revenue-131.0%+12.2%+3.0%-124.7%
Net MarginNet income ÷ Revenue-44.6%+1.5%+2.3%-3.3%
FCF MarginFCF ÷ Revenue-2.1%+9.6%-8.7%-3.9%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+7.7%+14.8%+64.7%
EPS Growth (YoY)Latest quarter vs prior year+84.0%-115.0%-114.1%+16.7%
USPH leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

CCM leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, USPH's 12.5x EV/EBITDA is more attractive than RDNT's 25.9x.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
Market CapShares × price$748,461$897M$4.5B$73M
Enterprise ValueMkt cap + debt − cash$547M$1.3B$5.5B$110M
Trailing P/EPrice ÷ TTM EPS-0.02x41.55x-230.00x-3.25x
Forward P/EPrice ÷ next-FY EPS est.1.23x20.63x91.75x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.52x25.88x
Price / SalesMarket cap ÷ Revenue0.01x1.15x2.18x2.32x
Price / BookPrice ÷ Book value/share0.00x1.16x3.19x0.39x
Price / FCFMarket cap ÷ FCF14.71x52.01x6.47x
CCM leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

USPH leads this category, winning 4 of 9 comparable metrics.

RDNT delivers a 3.8% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-11 for AFCG. AFCG carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), USPH scores 5/9 vs CCM's 3/9, reflecting solid financial health.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
ROE (TTM)Return on equity-9.8%+1.4%+3.8%-11.1%
ROA (TTM)Return on assets-2.4%+0.9%+1.3%-6.4%
ROICReturn on invested capital-7.7%+5.6%+2.0%-4.1%
ROCEReturn on capital employed-12.2%+7.6%+2.1%-5.6%
Piotroski ScoreFundamental quality 0–93554
Debt / EquityFinancial leverage2.43x0.55x1.37x0.43x
Net DebtTotal debt minus cash$3.7B$390M$1.1B$38M
Cash & Equiv.Liquid assets$216M$36M$767M$39M
Total DebtShort + long-term debt$3.9B$426M$1.9B$76M
Interest CoverageEBIT ÷ Interest expense-2.40x15.42x1.46x-2.15x
USPH leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

RDNT leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in RDNT five years ago would be worth $24,710 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, RDNT leads with a +4.6% total return vs AFCG's -35.5%. The 3-year compound annual growth rate (CAGR) favors RDNT at 26.0% vs CCM's -27.2% — a key indicator of consistent wealth creation.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
YTD ReturnYear-to-date+20.4%-24.6%-19.0%+10.2%
1-Year ReturnPast 12 months-28.4%-14.3%+4.6%-35.5%
3-Year ReturnCumulative with dividends-61.4%-43.7%+100.0%-20.1%
5-Year ReturnCumulative with dividends-84.9%-43.4%+147.1%-44.6%
10-Year ReturnCumulative with dividends-88.8%+22.6%+947.4%-42.4%
CAGR (3Y)Annualised 3-year return-27.2%-17.4%+26.0%-7.2%
RDNT leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCM and RDNT each lead in 1 of 2 comparable metrics.

CCM is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than AFCG's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RDNT currently trades 67.0% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
Beta (5Y)Sensitivity to S&P 5000.53x0.93x1.43x1.86x
52-Week HighHighest price in past year$10.77$93.50$85.84$5.87
52-Week LowLowest price in past year$3.18$58.55$50.76$2.06
% of 52W HighCurrent price vs 52-week peak+47.7%+63.1%+67.0%+52.6%
RSI (14)Momentum oscillator 0–10067.546.151.348.2
Avg Volume (50D)Average daily shares traded11K171K822K235K
Evenly matched — CCM and RDNT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — USPH and AFCG each lead in 1 of 2 comparable metrics.

Analyst consensus: CCM as "Buy", USPH as "Buy", RDNT as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs 60.0% for RDNT (target: $92). For income investors, AFCG offers the higher dividend yield at 28.10% vs USPH's 3.06%.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…RDNT logoRDNTRadNet, Inc.AFCG logoAFCGAdvanced Flower C…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$102.00$92.00
# AnalystsCovering analysts21211
Dividend YieldAnnual dividend ÷ price+3.1%+28.1%
Dividend StreakConsecutive years of raises0500
Dividend / ShareAnnual DPS$1.80$0.87
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.6%0.0%0.0%
Evenly matched — USPH and AFCG each lead in 1 of 2 comparable metrics.
Key Takeaway

USPH leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 2 tied.

Best OverallU.S. Physical Therapy, Inc. (USPH)Leads 2 of 6 categories
Loading custom metrics...

CCM vs USPH vs RDNT vs AFCG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CCM or USPH or RDNT or AFCG a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). U. S. Physical Therapy, Inc. (USPH) offers the better valuation at 41. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCM or USPH or RDNT or AFCG?

On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1.

2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CCM or USPH or RDNT or AFCG?

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCM or USPH or RDNT or AFCG?

By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.

53β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately 250% more volatile than CCM relative to the S&P 500. On balance sheet safety, Advanced Flower Capital Inc. (AFCG) carries a lower debt/equity ratio of 43% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCM or USPH or RDNT or AFCG?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCM or USPH or RDNT or AFCG?

RadNet, Inc.

(RDNT) is the more profitable company, earning 2. 3% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 2. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -138. 6% for CCM. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCM or USPH or RDNT or AFCG more undervalued right now?

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — CCM or USPH or RDNT or AFCG?

In this comparison, AFCG (28.

1% yield), USPH (3. 1% yield) pay a dividend. CCM, RDNT do not pay a meaningful dividend and should not be held primarily for income.

09

Is CCM or USPH or RDNT or AFCG better for a retirement portfolio?

For long-horizon retirement investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 3. 1% yield). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (USPH: +22. 6%, AFCG: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCM and USPH and RDNT and AFCG?

These companies operate in different sectors (CCM (Healthcare) and USPH (Healthcare) and RDNT (Healthcare) and AFCG (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CCM is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; RDNT is a small-cap quality compounder stock; AFCG is a small-cap income-oriented stock. USPH, AFCG pay a dividend while CCM, RDNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

RDNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Stocks Like

AFCG

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 32%
  • Dividend Yield > 11.2%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCM and USPH and RDNT and AFCG on the metrics below

Revenue Growth>
%
(CCM: -8.3% · USPH: 7.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.